Share

The NCI Cancer Prevention Fellowship Program will again host the NCI Summer Curriculum in Cancer Prevention in 2012

This educational opportunity has long been recognized as an opportunity for scientists, clinicians, and persons from other disciplines to learn the latest information about preventing cancer.  

The summer program consists of two separate courses:

The Principles and Practice of Cancer Prevention and Control Course is a 4 week course designed to give participants a broad-based perspective on the current state-of-the-science in the field of cancer prevention.  Experts representing disciplines from across the entire spectrum of cancer prevention research will present lectures on timely topics.  It will be held from July 9 – August 3, 2012 in Rockville, Maryland, with lectures from 8:30 am to 2:30 pm on most days.

The Molecular Prevention Course is a one week course that helps participants gain a stronger background in the molecular biology and genetics of cancer.  It provides a thorough overview of cutting-edge research in molecular epidemiology, chemoprevention, biomarkers, and translational research.  This course will be held from August 6 – August 10, 2012, also in Rockville, MD, with lectures from 8:30 am to 2:30 pm on most days.  Please visit our website for more information and to view syllabus samples from the 2011 Summer Curriculum in Cancer Prevention at https://cpfp.cancer.gov/summer/summer.php

Please share this opportunity with your fellows and trainees.  Registration for both courses is free but all registration materials need to be submitted by close of business on March 15, 2012 because space is limited.  Thank you.

For Additional Information contact: NIH, NCI, CCT, Cancer Prevention Fellowship Program   001 (301) 496-8640

If you are a person with a disability and require any assistive device, services or other reasonable accommodation to participate in this activity, please contact the Cancer Prevention Fellowship Program at 301-496-8640 to discuss your accommodation needs.

Susanne Radtke

Back to news list

Related News

  • EORTC: Advancing research and treatment for rare cancers

  • EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration

  • Appointment of Malte Peters as EORTC Strategic Alliance Officer

  • Unique series of workshops in partnership with the European Medicines Agency (EMA)

  • EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)

  • Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023

  • EORTC Quality of Life measures integrated in CDISC

  • EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma

  • Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia

  • New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023